Search

Your search keyword '"Cancer metastasis -- Drug therapy"' showing total 2,591 results
Start Over Descriptor "Cancer metastasis -- Drug therapy"
2,591 results on '"Cancer metastasis -- Drug therapy"'

1. Its time to take a different a targeted therapy:direction with: THE AND APPROVED SECOND-LINE (2L) ORAL to treat locally advanced or metastatic urothelial carcinoma expressing FGFR3 alterations/mutations that has progressed on or after at least one line of prior systemic therapy (1) Set a new direction with your 2L treatment decision (1)

Subjects
Drug therapy, Complications and side effects, Genetic aspects, Dosage and administration, Bladder cancer -- Drug therapy -- Genetic aspects, Kinase inhibitors -- Dosage and administration -- Complications and side effects, Antineoplastic agents -- Dosage and administration -- Complications and side effects, Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy, Antimitotic agents -- Dosage and administration -- Complications and side effects
Abstract

BALVERSA[R] (erdafitinib) is a kinase inhibitor indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC) with susceptible FGFR3 genetic alterations whose disease has progressed [...]

Published
2024

2. Data from Faculty of Medicine and Health Sciences Provide New Insights into Personalized Medicine [Paradigm of Biomarkers In Metastatic Melanoma (Review)]

Subjects
Drug therapy, Precision medicine, Physical fitness, Skin cancer -- Drug therapy, Melanoma -- Drug therapy, Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy
Abstract

2025 FEB 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Drugs and Therapies - Personalized Medicine is the subject [...]

Published
2025

3. Heart drug dissolves breast cancer cell clusters in the blood

Subjects
Drug therapy, Reports, Cancer prevention -- Reports, Cancer research -- Reports, Cancer metastasis -- Drug therapy, Breast cancer -- Drug therapy, Digoxin -- Reports, Oncology, Experimental -- Reports, Metastasis -- Drug therapy, Cancer -- Prevention -- Research
Abstract

Digoxin, a heart medication, dissolves clusters of circulating breast cancer cells in the blood, reducing the risk of metastases formation, researchers report. Certain tumor types do not remain at their [...]

Published
2025

4. US FDA approves label expansion for Roche's Pathway HER2 (4B5) test to identify patients with HER2-ultralow metastatic breast cancer eligible for Enhertu

Subjects
United States. Food and Drug Administration, Enhertu (Medication), Drug therapy, Antibodies, Labels, Cancer metastasis -- Drug therapy, Biological products, Breast cancer -- Drug therapy, Metastasis -- Drug therapy, Viral antibodies
Abstract

Roche announced that the US Food and Drug Administration (FDA) has approved a label expansion for the Pathway anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody to identify patients with HR-positive, HER2-ultralow [...]

Published
2025

5. BridgeBio Receives U.S. FDA Fast Track Designation for BBO-8520 for KRASG12C-Mutated Metastatic Non-Small Cell Lung Cancer

Subjects
United States. Food and Drug Administration, Drug therapy, Small cell lung cancer -- Drug therapy, Cancer metastasis -- Drug therapy, Non-small cell lung cancer -- Drug therapy, Metastasis -- Drug therapy, Lung cancer, Small cell -- Drug therapy, Lung cancer, Non-small cell -- Drug therapy
Abstract

JTheRas, Inc. d/b/a BridgeBio Oncology Therapeutics (BBOT' or the 'Company), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, reported that the U.S. Food and Drug Administration (FDA) has granted Fast [...]

Published
2025

6. Amgen receives US FDA approval for Lumakras in combo with Vectibix for chemorefractory KRAS G12C-mutated metastatic colorectal cancer

Subjects
United States. Food and Drug Administration, Vectibix (Medication), Drug therapy, Trifluridine, Panitumumab, Regorafenib, Chemotherapy, Tipiracil, Colorectal cancer -- Drug therapy, Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy, Cancer -- Chemotherapy
Abstract

Amgen announced that the US Food and Drug Administration (FDA) has approved Lumakras (sotorasib) in combination with Vectibix (panitumumab) for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal [...]

Published
2025

7. Daiichi Sankyo & AstraZeneca's Datroway gets US FDA approval for patients with previously treated metastatic HR positive, HER2 negative breast cancer

Subjects
Daiichi Sankyo Inc., AstraZeneca PLC, Drug therapy, Chemotherapy, Antibodies, Cancer metastasis -- Drug therapy, Biological products, Breast cancer -- Drug therapy, Metastasis -- Drug therapy, Viral antibodies, Cancer -- Chemotherapy
Abstract

Datroway (datopotamab deruxtecan-dlnk) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ or [...]

Published
2025

8. Migrastatic Therapy as a Potential Game-Changer inAdaptive Cancer Treatment

Subjects
Drug therapy, Cancer treatment, Physical fitness, Prostate cancer -- Drug therapy, Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy, Cancer -- Care and treatment
Abstract

2025 JAN 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained [...]

Published
2025

9. US FDA accepts and grants priority review status to AstraZeneca & Daiichi Sankyo's BLA for Dato-DXd for patients with previously treated advanced EGFR-mutated NSCLC

Subjects
AstraZeneca PLC -- Technology application, United States. Food and Drug Administration -- Government finance, Drug therapy, Technology application, Government finance, Durvalumab -- Government finance -- Technology application, Osimertinib -- Technology application -- Government finance, Patient compliance -- Government finance -- Technology application, Epidermal growth factors -- Technology application -- Government finance, Drug approval -- Government finance -- Technology application, Non-small cell lung cancer -- Drug therapy, Cancer metastasis -- Drug therapy, Prescriptions (Drugs) -- Technology application -- Government finance, Metastasis -- Drug therapy, Drugs -- Prescribing, Lung cancer, Non-small cell -- Drug therapy, Epidermal growth factor -- Technology application -- Government finance
Abstract

AstraZeneca and Daiichi Sankyo's Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted and granted Priority Review in the US for the treatment of adult patients with locally [...]

Published
2025

10. Findings from Institute for Cancer Research and Treatment (IRCCS) Broaden Understanding of Liver Metastasis [Hepatocellular Carcinoma (Hcc) Tumor Microenvironment Is More Suppressive Than Colorectal Cancer Liver Metastasis (Crlm) Tumor ...]

Subjects
Drug therapy, Reports, Health aspects, Cancer treatment -- Health aspects -- Reports, Physical fitness -- Health aspects -- Reports, Cancer research -- Health aspects -- Reports, Colorectal cancer -- Drug therapy, Cancer metastasis -- Drug therapy, Oncology, Experimental -- Health aspects -- Reports, Metastasis -- Drug therapy, Cancer -- Care and treatment -- Research
Abstract

2025 JAN 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Oncology - Liver Metastasis. According to news [...]

Published
2025

11. Data from Institute of Biomedical and Genetic Engineering Update Knowledge in Apoptosis (TRAIL as a Warrior in Nano-Sized Trojan Horse: Anticancer and Anti-Metastatic Effects of Nano-Formulations of TRAIL in Cell Culture and Animal Model Studies)

Subjects
Drug therapy, Analysis, Malware -- Analysis, Genetically modified organisms -- Analysis, Apoptosis -- Analysis, Physical fitness -- Analysis, Drug resistance -- Drug therapy, Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy, Spyware -- Analysis
Abstract

2024 DEC 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in apoptosis. According to news reporting originating from [...]

Published
2024

12. Ohio State University Wexner Medical Center Researcher Reports Recent Findings in Colon Cancer (Precision Medicine for Metastatic Colorectal Cancer: Where Do We Stand?)

Subjects
Drug therapy, Precision medicine, Cancer treatment, Physical fitness, Medical centers, Cancer research, Colorectal cancer -- Drug therapy, Cancer metastasis -- Drug therapy, Oncology, Experimental, Metastasis -- Drug therapy, Cancer -- Care and treatment -- Research
Abstract

2024 DEC 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on colon cancer have been presented. According to news reporting [...]

Published
2024

13. US FDA approves Jazz Pharma's Ziihera to treat adults with previously treated, unresectable or metastatic HER2-positive biliary tract cancer

Subjects
United States. Food and Drug Administration, Drug therapy, Cancer metastasis -- Drug therapy, Adults, Biliary tract cancer -- Drug therapy, Metastasis -- Drug therapy
Abstract

Jazz Pharmaceuticals plc announced the US Food and Drug Administration (FDA) accelerated approval of Ziihera (zanidatamab-hrii) 50mg/mL for injection for intravenous use for the treatment of adults with previously treated, [...]

Published
2024

16. Data from Hamilton Health Sciences Broaden Understanding of Carcinomas (Efficacy and Safety of Lenvatinib in Combination With Other Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma)

Subjects
Drug therapy, Physical fitness, Tyrosine, Lenvatinib, Renal cell carcinoma -- Drug therapy, Phenols (Class of compounds), Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy, Phenols, Carcinoma, Renal cell -- Drug therapy
Abstract

2024 NOV 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on carcinomas is the subject of a new report. According [...]

Published
2024

17. AstraZeneca, Daiichi Sankyo seek US FDA's accelerated approval for datopotamab deruxtecan to treat advanced EGFR-mutated NSCLC

Subjects
AstraZeneca PLC, Drug therapy, Durvalumab, Clinical trials, Osimertinib, Epidermal growth factors, Pharmaceutical industry, Drug approval, Non-small cell lung cancer -- Drug therapy, Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy, Lung cancer, Non-small cell -- Drug therapy, Epidermal growth factor
Abstract

AstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application (BLA) for accelerated approval in the US for datopotamab deruxtecan (Dato-DXd) for the treatment of adult patients with locally [...]

Published
2024

18. Ministry of Health of Russia Researchers Update Current Data on Thyroid Cancer (Observation and treatment of patients with progressive metastatic differentiated thyroid cancer after establishment of radioiodine refractoriness)

Subjects
Drug therapy, Thyroid cancer -- Drug therapy, Physical fitness, Cancer research, Cancer metastasis -- Drug therapy, Oncology, Experimental, Metastasis -- Drug therapy, Cancer -- Research
Abstract

2024 NOV 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on thyroid cancer. According to news reporting out [...]

Published
2024

19. Department of Internal Medicine Researcher Targets Liver Cancer (Metastasis to the skull base involving the sphenoid and cavernous sinus in hepatocellular carcinoma)

Subjects
Drug therapy, Physical fitness, Hepatocellular carcinoma -- Drug therapy, Cancer research, Sorafenib, Cancer metastasis -- Drug therapy, Oncology, Experimental, Metastasis -- Drug therapy, Cancer -- Research, Hepatoma -- Drug therapy
Abstract

2024 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New study results on liver cancer have been published. According to news [...]

Published
2024

20. Data from Shanghai Jiao Tong University School of Medicine Update Knowledge in Lung Cancer [Evaluation of the prognostic value of the new 9th edition Tumor-Node-Metastases (TNM) staging system for epidermal growth factor receptor (EGFR)-mutated ...]

Subjects
Drug therapy, Lung cancer -- Drug therapy, Osimertinib, Epidermal growth factors, Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy, Epidermal growth factor
Abstract

2024 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on lung cancer have been published. According to news [...]

Published
2024

21. Data on Non-Small Cell Lung Cancer Described by Researchers at Jiangsu University (Immune Checkpoint Inhibitors With or Without Radiotherapy In Metastatic Non-small Cell Lung Cancer: a Meta-analysis and Literature Review)

Subjects
Drug therapy, Analysis, Reports, Physical fitness -- Analysis -- Reports, Cancer research -- Reports -- Analysis, Biochemistry -- Analysis -- Reports, Small cell lung cancer -- Drug therapy, Radiotherapy -- Analysis -- Reports, Non-small cell lung cancer -- Drug therapy, Cancer metastasis -- Drug therapy, Oncology, Experimental -- Reports -- Analysis, Metastasis -- Drug therapy, Lung cancer, Small cell -- Drug therapy, Lung cancer, Non-small cell -- Drug therapy, Cancer -- Research
Abstract

2024 OCT 12 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Oncology - Non-Small Cell Lung Cancer are discussed in [...]

Published
2024

22. FDA approves Roche's inavolisib combo for metastatic breast cancer

Subjects
United States. Food and Drug Administration, Drug therapy, Palbociclib, Fulvestrant, Breast cancer -- Drug therapy, Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy
Abstract

The Food and Drug Administration approved inavolisib, or Itovebi, from Genentech, with palbociclib and fulvestrant for adults with endocrine-resistant, PIK3CA-mutated, hormone receptor-positive, human epidermal growth-factor receptor 2-negative, locally advanced or [...]

Published
2024

23. Theriva achieves target patient enrollment in VIRAGE phase 2b trial of VCN-01 with gemcitabine/nab-paclitaxel to treat metastatic pancreatic cancer

Subjects
United States. Food and Drug Administration, Drug therapy, Product development, Clinical trials, Pancreatic cancer -- Drug therapy, Chemotherapy, Antineoplastic agents -- Product development, Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy, Cancer -- Chemotherapy, Antimitotic agents -- Product development
Abstract

Theriva Biologics, Inc., a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, announced that it has achieved their target patient [...]

Published
2024

24. Studies from University of Ulsan College of Medicine Provide New Data on Breast Cancer (Longitudinal dynamics of circulating tumor DNA for treatment monitoring in patients with breast cancer recurrence)

Subjects
Drug therapy, Analysis, Cancer recurrence -- Drug therapy, Physical fitness -- Analysis, Cancer genetics -- Drug therapy, Genetic research -- Analysis, Cancer research -- Analysis, DNA -- Analysis, Cancer patients -- Drug therapy, Cancer metastasis -- Drug therapy, Breast cancer -- Drug therapy, Patient monitoring equipment -- Analysis, Oncology, Experimental -- Analysis, Metastasis -- Drug therapy, Cancer -- Genetic aspects -- Relapse -- Research
Abstract

2024 SEP 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on breast cancer is the subject of a new report. [...]

Published
2024

25. Investigators from Shenyang University of Chemical Technology Have Reported New Data on Drug Research (Design, Synthesis and Pharmacological Evaluation of Novel 4-phenoxyquinoline Derivatives As Vegfr2 Kinase Inhibitors for Tumor Treatment)

Subjects
Drug therapy, Analysis, Reports, Physical fitness -- Analysis -- Reports, Endothelial growth factors -- Reports -- Analysis, Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy
Abstract

2024 SEP 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Drug Research are presented in a new report. According [...]

Published
2024

26. Merck gets US FDA approval for Keytruda plus pemetrexed & platinum chemotherapy to treat unresectable advanced or metastatic MPM

Subjects
Merck Research Laboratories, United States. Food and Drug Administration, Keytruda (Medication), Drug therapy, Chemotherapy, Pharmaceutical industry, Pemetrexed, Drug approval, Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy, Cancer -- Chemotherapy
Abstract

Merck, known as MSD outside of the United States and Canada, announced the US Food and Drug Administration (FDA) has approved Keytruda, Merck's anti-PD-1 therapy, in combination with pemetrexed and [...]

Published
2024

27. Data from University of Utah Broaden Understanding of Wilms' Tumor (Pediatric regimens in the treatment of adult-onset, metastatic Wilms tumor: A case report)

Subjects
The University of Utah, Drug therapy, Physical fitness, Pediatrics, Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy
Abstract

2024 SEP 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Wilms' tumor have been presented. According to news originating [...]

Published
2024

28. Data from Zhengzhou University Provide New Insights into Squamous Cell Carcinoma (Luteolin Enhances Drug Chemosensitivity By Downregulating the Fak/pi3k/akt Pathway In Paclitaxel-resistant Esophageal Squamous Cell Carcinoma)

Subjects
Drug therapy, Paclitaxel, Flavonoids, Drug resistance -- Drug therapy, Squamous cell carcinoma -- Drug therapy, Stem cells, Cancer metastasis -- Drug therapy, Esophageal cancer -- Drug therapy, Bioflavonoids, Flavones, Metastasis -- Drug therapy
Abstract

2024 SEP 2 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- Investigators publish new report on Oncology - Squamous Cell Carcinoma. According to news originating [...]

Published
2024

29. Studies from Stanford Medicine Provide New Data on Breast Cancer (Durable Responses To Trastuzumab Deruxtecan In Patients With Leptomeningeal Metastases From Breast Cancer With Variable Her2 Expression)

Subjects
Drug therapy, Physical fitness, Cancer research, Breast cancer -- Drug therapy, Cancer metastasis -- Drug therapy, Trastuzumab, Oncology, Experimental, Metastasis -- Drug therapy, Cancer -- Research
Abstract

2024 AUG 31 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Oncology - Breast Cancer have been presented. According to [...]

Published
2024

30. Studies from Astellas Pharma Inc. Add New Findings in the Area of Urothelial Cancer (Population Pharmacokinetic Modeling and Exposure-response Analysis for the Antibody-drug Conjugate Enfortumab Vedotin In Locally Advanced or Metastatic ...)

Subjects
Astellas Pharma Inc., Drug therapy, Models, Physical fitness -- Models, Enfortumab vedotin -- Models, Monoclonal antibodies -- Models, Cancer -- Drug therapy, Cancer research -- Models, Biopharmaceuticals -- Models, Pharmaceutical industry -- Models, Cancer metastasis -- Drug therapy, Oncology, Experimental -- Models, Biopharmaceutics -- Models, Metastasis -- Drug therapy, Cancer -- Drug therapy -- Research
Abstract

2024 AUG 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Oncology - Urothelial Cancer. According to news [...]

Published
2024

31. Reports from University of Rochester Medical Center Advance Knowledge in Health and Medicine (Hyaluronidase inhibitor delphinidin inhibits cancer metastasis)

Subjects
Drug therapy, Reports, Physical fitness -- Reports, Medical centers -- Reports, Cancer -- Drug therapy, Cancer metastasis -- Drug therapy, Hyaluronic acid -- Reports, Metastasis -- Drug therapy
Abstract

2024 JUL 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on agriculture are discussed in a new report. According to [...]

Published
2024

32. Investigators from Institute for Molecular Medicine Have Reported New Data on Cancer (Membrane Lipid Replacement for Reconstituting Mitochondrial Function and Moderating Cancer-related Fatigue, Pain and Other Symptoms While Counteracting the ...)

Subjects
Drug therapy, Physical fitness, Cancer -- Drug therapy, Fatigue -- Drug therapy, Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy
Abstract

2024 JUL 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Cancer. According to news reporting originating from [...]

Published
2024

33. Tiragolumab Combo Misses Endpoints in Metastatic Non-Squamous NSCLC Trial

Author

Park, Brian

Subjects
Drug therapy, Atezolizumab, Chemotherapy, Pembrolizumab, Cancer metastasis -- Drug therapy, Non-small cell lung cancer -- Drug therapy, Metastasis -- Drug therapy, Lung cancer, Non-small cell -- Drug therapy, Cancer -- Chemotherapy
Abstract

A phase 3 study evaluating tiragolumab, a novel immune checkpoint inhibitor, in adults with previously untreated, locally advanced unresectable or metastatic non-squamous non-small cell lung cancer (nSq NSCLC) did not [...]

Published
2024

34. Reports on Carcinomas from University of Science and Technology China Provide New Insights (Successful Treatment of Trichilemmal Carcinoma With Distant Metastasis Using Pembrolizumab: a Case Report and Review)

Subjects
Drug therapy, Health aspects, Cancer treatment -- Health aspects, Physical fitness -- Health aspects, Carcinoma -- Drug therapy, Pembrolizumab -- Health aspects, Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy, Cancer -- Care and treatment -- Drug therapy
Abstract

2024 JUL 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Carcinomas have been published. According to [...]

Published
2024

35. Oncoinvent receives US FDA fast track designation for Radspherin to treat patients with peritoneal metastases from ovarian cancer

Subjects
United States. Food and Drug Administration, Drug therapy, Colorectal cancer -- Drug therapy, Cancer patients -- Drug therapy, Cancer metastasis -- Drug therapy, Ovarian cancer -- Drug therapy, Metastasis -- Drug therapy
Abstract

Oncoinvent AS, a clinical stage radiopharmaceutical company advancing alpha emitter therapy across a variety of peritoneal metastases, announced that the US Food and Drug Administration (FDA) has granted Fast Track [...]

Published
2024

36. Investigators from Weill Cornell Medicine Target Cancer [Characterizing 'collateral Damage' In Men and Women With Metastatic Breast Cancer (Mbc) From Diverse Racial and Ethnic Backgrounds In New York City]

Subjects
Drug therapy, Diseases, Reports, Physical fitness -- Reports, Cancer metastasis -- Drug therapy, Breast cancer -- Drug therapy, Metastasis -- Drug therapy
Abstract

2024 JUN 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Cancer. According to news originating from New [...]

Published
2024

37. University of Manchester Researchers Illuminate Research in Prostate Cancer (Comparison of standard-dose and reduced-dose treatment of metastatic prostate cancer with enzalutamide, apalutamide or darolutamide: a rapid review)

Subjects
University of Manchester -- Standards, Drug therapy, Standards, Comparative analysis, Cancer treatment -- Comparative analysis, Physical fitness -- Comparative analysis, Enzalutamide -- Comparative analysis, Cancer research -- Comparative analysis, Darolutamide -- Standards, Prostate cancer -- Drug therapy, Cancer metastasis -- Drug therapy, Apalutamide -- Standards, Oncology, Experimental -- Comparative analysis, Metastasis -- Drug therapy, Cancer -- Care and treatment -- Research
Abstract

2024 JUN 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on prostate cancer have been presented. According to news reporting [...]

Published
2024

38. Researchers from King Abdulaziz University Detail Research in Cancer (Diagnosis, investigation, and treatment of occult breast cancer: A case report and systematic review of the literature)

Subjects
King Abdulaziz University -- Investigations, Drug therapy, Investigations, Company legal issue, Cancer treatment -- Investigations, Cancer diagnosis -- Investigations, Physical fitness -- Investigations, Cancer research -- Investigations, Breast cancer -- Drug therapy, Cancer metastasis -- Drug therapy, Oncology, Experimental -- Investigations, Cancer -- Diagnosis -- Care and treatment -- Research, Metastasis -- Drug therapy
Abstract

2024 JUN 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on cancer have been presented. According to news reporting out [...]

Published
2024

39. Roche receives FDA approval for the first companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for ENHERTU

Subjects
United States. Food and Drug Administration, Enhertu (Medication) -- Labeling, Drug therapy, Labeling, Cancer metastasis -- Drug therapy, Biological products -- Labeling, Breast cancer -- Drug therapy, Metastasis -- Drug therapy
Abstract

Basel: Hoffmann-La Roche has issued the following press release: Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved a label expansion [...]

Published
2025

40. FDA APPROVES LUMAKRAS(r) (SOTORASIB) IN COMBINATION WITH VECTIBIX(r) (PANITUMUMAB) FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER

Subjects
United States. Food and Drug Administration, Vectibix (Medication), Drug therapy, Cancer treatment, Trifluridine, Panitumumab, Regorafenib, Tipiracil, Colorectal cancer -- Drug therapy, Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy, Cancer -- Care and treatment
Abstract

THOUSAND: Amgen has issued the following news release: Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved LUMAKRAS(r) (sotorasib) in combination with Vectibix(r) (panitumumab) for [...]

Published
2025

41. Breakthrough, Life-Saving Cancer Treatment, TIL Therapy, Offers New Hope to Patients with Metastatic Melanoma

Subjects
Drug therapy, Health aspects, Cancer treatment -- Health aspects, Immunotherapy -- Health aspects, Melanoma -- Drug therapy, Drug approval -- Health aspects, Cancer metastasis -- Drug therapy, T cells -- Health aspects, Metastasis -- Drug therapy, Cancer -- Care and treatment
Abstract

WASHINGTON: MedStar Georgetown University Hospital has issued the following news release: MedStar Georgetown University Hospital is the first hospital in the Washington metropolitan area to offer Tumor-Infiltrating Lymphocyte therapy, or [...]

Published
2025

42. Innovent Announces Second New Drug Application of DOVBLERON (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration

Subjects
Drug therapy, Medical supplies, Drug approval, Ophthalmology, Non-small cell lung cancer -- Drug therapy, Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy, Lung cancer, Non-small cell -- Drug therapy
Abstract

SAN FRANCISCO and SUZHOU, China, Jan. 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the [...]

Published
2025

43. Erdafitinib in the Treatment of Metastatic Urothelial Carcinoma

Author

Castro-Alonso, Francisco, Beas-Lozano, Evelyn, Remolina-Bonilla, Yuly A., Flaig, Thomas W., and Bourlon, Maria T.

Subjects
Drug therapy, Atezolizumab, Cancer -- Drug therapy, Chemotherapy, Avelumab, Pembrolizumab, Cancer metastasis -- Drug therapy, Medical schools, Metastasis -- Drug therapy, Medical colleges, Cancer -- Drug therapy -- Chemotherapy
Abstract

Platinum-based chemotherapy is the standard first-line treatment for patients with MUBC, with either cisplatin or carboplatin combinations. (1-4) In patients whose disease does not progress on chemotherapy, maintenance with avelumab [...]

Published
2023

45. Retevmo Approved for Younger Patients With RET-Driven Thyroid Cancer, Solid Tumors

Author

Park, Brian

Subjects
United States. Food and Drug Administration, Retevmo (Medication), Drug therapy, Thyroid cancer -- Drug therapy, Cancer genetics -- Drug therapy, Child health, Cancer metastasis -- Drug therapy, Metastasis -- Drug therapy, Cancer -- Genetic aspects, Children -- Health aspects
Abstract

The Food and Drug Administration (FDA) has granted accelerated approval to Retevmo (selpercatinib) for the treatment of pediatric patients 2 years of age and older with: * Advanced or metastatic [...]

Published
2024

46. Reports Outline Prostate Cancer Study Findings from Memorial Sloan-Kettering Cancer Center (Phase I Study of Oric-101, a Glucocorticoid Receptor Antagonist, In Combination With Enzalutamide In Patients With Metastatic Castration-resistant ...)

Subjects
Testing, Drug therapy, Health aspects, Pharmaceutical research, Enzalutamide -- Testing, Combination drug therapy -- Testing, Prostate cancer -- Drug therapy, Glucocorticoids -- Health aspects, Cancer metastasis -- Drug therapy, Hormone antagonists -- Testing, Corticosteroids -- Health aspects, Metastasis -- Drug therapy, Drug therapy, Combination -- Testing
Abstract

2024 APR 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Oncology - Prostate Cancer are discussed in a new [...]

Published
2024

47. Dokuz Eylul University Researchers Further Understanding of Colon Cancer (In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens)

Subjects
Drug therapy, Cancer treatment, Medical tests, Physical fitness, Cancer research, Colorectal cancer -- Drug therapy, Antineoplastic agents, Cancer metastasis -- Drug therapy, Microfluidics, Oncology, Experimental, Metastasis -- Drug therapy, Cancer -- Care and treatment -- Research, Antimitotic agents
Abstract

2024 APR 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on colon cancer have been published. According to news [...]

Published
2024

48. Studies from Hull York School of Medicine Have Provided New Information about Cancer (trans-iv Restriction: a New Configuration for Metal Bis-cyclam Complexes As Potent Cxcr4 Inhibitors)

Subjects
Drug therapy, Physical fitness, Cancer -- Drug therapy, Cancer research, Plerixafor, Cancer metastasis -- Drug therapy, Oncology, Experimental, Metastasis -- Drug therapy, Cancer -- Drug therapy -- Research
Abstract

2024 APR 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Cancer are presented in a new report. According to [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results